Product Categories
Country: | United States |
---|---|
Tel: | 001-619-354-5251 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Company Name: | Alabiotech Inc. |
Tel: | 001-619-354-5251 |
Fax: | 001-855-855-6087 |
Email: | sales@alabiotech-e.com |
WebSite: | http://www.alabiotech-e.com |
Nationality: | United States |
Product Name | MF | CAS | Details |
---|
Fmoc-N-Me-Thr(Bzl)-OH | C27H27NO5 | 198561-81-8 | Details |
Fmoc-β-HoSer(tBu)-OH | C23H27NO5 | 203854-51-7 | Details |
H-Dap(Fmoc)-OBzl.HCl | Details |
H-D-Dap(Fmoc)-OBzl.HCl | C25H25ClN2O4 | 2044711-00-2 | Details |
H-N-Me-Ala-OMe.HCl | Details |
H-D-β-HoSer-OH | C4H9NO3 | 16504-57-7 | Details |
GM 6001, Negative Control | C23H34N4O4 | 877381-76-5 | Details |
Granzyme B Inhibitor I | C19H24ClN3O7 | Details |
Ilomastat | C20H28N4O4 | 142880-36-2 | Details |
GM 1489 | C27H33N3O4 | 170905-75-6 | Details |
hemiasterlin C | Details |
Fmoc-N-Me-Ile-OH | C22H25NO4 | 138775-22-1 | Details |
Fmoc-norArg(Pbf)-OH | C33H38N4O7S | 1313054-32-8 | Details |
H-Dab(Boc)-OBzl.HCl | Details |
H-D-Dab(Boc)-OBzl.HCl | C16H25ClN2O4 | 2044710-29-2 | Details |
Fmoc-Sec(Trt)-OH | C37H31NO4Se | 1639843-37-0 | Details |
Fmoc-N-Me-Ser-OH | C19H19NO5 | 291311-48-3 | Details |
H-Dab(Boc)-OtBu.HCl | Details |
Fmoc-N-Me-Lys(Boc)-OH | C27H34N2O6 | 197632-76-1 | Details |
H-N-Me-D-Ala-OH | C4H9NO2·HCl | Details |
Fmoc-norArg(Boc)2-OH | Details |
Fmoc-β-Homoselenomethionine | Details |
Fmoc-N-Me-Lys(N3)-OH | C22H24N4O4 | Details |
H-N-Me-D-Ala-OMe.HCl | Details |
Hdm2 E3 Ligase Inhibitor | C10H8F6N2O3S | 414905-09-2 | Details |
Fmoc-Orn(Boc)-OH | C25H30N2O6 | 109425-55-0 | Details |
Fmoc-Pip(Boc)-OH | C26H30N2O6 | 183673-66-7 | Details |
GUANIDINOSUCCINIC ACID | C5H9N3O4 | 6133-30-8 | Details |
Fmoc-Orn(Dde)-OH | C30H34N2O6 | 269062-80-8 | Details |
Fmoc-Orn(ivDde)-OH | C33H40N2O6 | 1198321-33-3 | Details |
H-D-Gla-OH | C6H9NO6 | 64153-47-5 | Details |
H-HoLeu-OH·HCl | C7H15NO2 | 31872-98-7 | Details |
H2N-PEG3-CH2CH2NH2;1,11-Diamino-3-6-9-trioxaundecane | C8H20N2O3 | 929-75-9 | Details |
H-D-HoLeu-OH·HCl | C7H15NO2 | 138751-02-7 | Details |
Fmoc-Sec(Mob)-OH | C26H25NO5Se | 150308-80-8 | Details |
H-N-Me-Ala-OH | C4H9NO2 | 3913-67-5 | Details |
H2N-PEG6-CH2CH2COOH | C15H31NO8 | 905954-28-1 | Details |
H-N-Me-Arg-OH.HCl | C7H17ClN4O2 | 709025-91-2 | Details |
H2N-PEG5-CH2COOH | C12H25NO7 | 141282-35-1 | Details |
H-Lys(nicotinoyl)-OH·HCl | C12H17N3O3 | 158276-23-4 | Details |
Fmoc-norArg(Me,pbf)-OH | C34H40N4O7S | 2044704-60-9 | Details |
H-Dap(Boc)-OMe.HCl | C9H19ClN2O4 | 114559-25-0 | Details |
Fmoc-N-Me-HomoCys(Trt)-OH | C39H35NO4S | 526210-71-9 | Details |
Granzyme B Inhibitor IV | C22H34N4O9 | 352520-90-2 | Details |
Gly-Tyr-Gly-Gly-Phe-Met | C29H38N6O8S | 70013-23-9 | Details |
Fosamprenavir | C25H36N3O9PS | 226700-79-4 | Details |
Fmoc-N-Me-Phe-OH | C25H23NO4 | 77128-73-5 | Details |
H-Dab(Fmoc)-OBzl.HCl | Details |
H-D-Dab(Fmoc)-OBzl.HCl | Details |
Fmoc-N-Me-Trp(Trt)-OH | C46H38N2O4 | Details |
H-D-Se-Met-OH.HCl | Details |
H-Dap(Boc)-OtBu.HCl | Details |
Fmoc-Thr(PO(OBzl)OH)-OH | C26H26NO8P | 175291-56-2 | Details |
Fmoc-N-Me-Ser(tBu)-OH | C23H27NO5 | 197632-77-2 | Details |
H-D-Lys(Boc)-OMe.HCl | C12H25ClN2O4 | 66494-53-9 | Details |
Fmoc-N-Me-Trp(Boc)-OH | C32H32N2O6 | 197632-75-0 | Details |
Fmoc-N-Me-Thr(tBu)-OH | C24H29NO5 | 117106-20-4 | Details |
Hemiasterlin B | Details |
Fmoc-Sec(pMeBzl)-OH | Details |
Fmoc-N-Me-Nle-OH | C22H25NO4 | 112883-42-8 | Details |
Fmoc-N-Me-Met-OH | Details |
H-N-Me-D-Arg-OH.HCl | Details |
Fmoc-Orn(Dnp)-OH | C26H24N4O8 | 252049-04-0 | Details |
Hemiasterlin | Details |
Fmoc-N-Me-Leu-OH | C22H25NO4 | 103478-62-2 | Details |
H-Gly-Arg-Gly-Asp-Ser-OH | C17H30N8O9 | 96426-21-0 | Details |
Fmoc-Thr(tBu)-Ol | C23H29NO4 | 189337-28-8 | Details |
Fosamprenavir calcium | C25H34CaN3O9PS | 226700-81-8 | Details |
Fmoc-N-Me-Val-OH | C21H23NO4 | 84000-11-3 | Details |
GGTI-2147 | C28H30N4O3 | 191102-87-1 | Details |
Fmoc-N-Me-Nva-OH | C21H23NO4 | 252049-05-1 | Details |
H2N-PEG6-OH | C12H27NO6 | 39160-70-8 | Details |
H-N-Me-Asn-OH. | Details |
H-Aad-OH | C6H11NO4 | 1118-90-7 | Details |
fyk-1388 | C30H44N6O6 | 184947-92-0 | Details |
H-LYS-THR-GLU-GLU-ILE-SER-GLU-ASN-STA-VAL-ALA-GLU-PHE-OH | C68H109N15O26 | Details |
H-D-Dap(Boc)-OMe.HCl | C9H18N2O4 | 363191-25-7 | Details |
FTase Inhibitor I | C22H38N4O3S2 | 149759-96-6 | Details |
Fmoc-N-Me-Tyr(tBu)-OH | C29H31NO5 | 133373-24-7 | Details |
Fmoc-β-HomoSec(Mob)-OH | Details |
H-Dap(Boc)-OBzl.HCl | C15H23ClN2O4 | 2044704-52-9 | Details |
H-D-Dap(Boc)-OBzl.HCl | C15H23ClN2O4 | 2044710-53-2 | Details |
Fmoc-N-Me-HoArg(pbf)-OH | C36H44N4O7S | 2044711-15-9 | Details |
H-Gla-OH | C6H9NO6 | 53861-57-7 | Details |
H-Lys(Boc)-OMe.HCl | C12H25ClN2O4 | 2389-48-2 | Details |
H-D-Aad-OH | C6H11NO4 | 542-32-5 | Details |
H-LYS-THR-GLU-GLU-ILE-SER-GLU-VAL-ASN-STA-VAL-ALA-GLU-PHE-OH | C73H118N16O27 | 350228-37-4 | Details |
H-Dab(Boc)-OMe.HCl | C10H21ClN2O4 | 3350-15-0 | Details |
Fmoc-N-Me-Orn(Boc)-OH | C26H32N2O6 | Details |
H-N-Me-D-Asn-OH | Details |
H2N-PEG3-CH2CH2COOtBu | C13H27NO5 | 252881-74-6 | Details |
Fmoc-N-Me-Tyr(Bzl)-OH | C32H29NO5 | 428868-52-4 | Details |
Group III Caspase Inhibitor I | C28H39FN4O10 | 1135688-47-9 | Details |
Fmoc-Ser(PO(OBzl)OH)-OH | C25H24NO8P | 158171-14-3 | Details |
H-Arg-Gly-Asp-Ser-OH | C15H27N7O8 | 91037-65-9 | Details |
Fmoc-Orn(Alloc)-OH | C24H26N2O6 | 147290-11-7 | Details |
Fmoc-Orn(N3)-OH | C20H20N4O4 | 1097192-04-5 | Details |
Fmoc-N-Me-Lys(2-Cl-Z)-OH | C30H31ClN2O6 | Details |
Granzyme B Inhibitor II | C21H34N4O10 | 1258003-96-1 | Details |
Fmoc-Orn(Mtt)-OH | C40H38N2O4 | 343770-23-0 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 |